Transaction DateRecipientSharesTypePriceValue
7th January 2021Advisors Llc Orbimed2,000,000Open or private sale$3.50$7,000,000.00
28th December 2020Advisors Llc Orbimed600,000Open or private sale$14.25$8,550,000.00
8th December 2020Advisors Llc Orbimed2,493,741Conversion of derivative$0.00
8th December 2020Advisors Llc Orbimed21,400Open or private sale$1.96$41,944.00
8th December 2020Advisors Llc Orbimed1,055,287Conversion of derivative$0.00
8th December 2020Advisors Llc Orbimed952,377Open or private purchase$21.00$19,999,917.00
8th December 2020Advisors Llc Orbimed238,100Open or private purchase$21.00$5,000,100.00
8th December 2020Advisors Llc Orbimed21,400Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.96$20,544.00
8th December 2020Advisors Llc Orbimed3,462,737Conversion of derivative$0.00
7th December 2020Advisors Llc Orbimed118,794Conversion of derivative$0.00
Principia Biopharma
Principia Biopharma logo

Principia Biopharma, Inc. is a biopharmaceutical company. It engages in design and development oral therapies to patients with significant unmet medical needs in immunology and oncology. The company was founded by Jack Taunton and Richard A. Miller on October 28, 2008.

Ticker: PRNB
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1510487
Employees: 103
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags